ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,346,000 | -28.8% | 510,000 | 0.0% | 1.27% | -31.5% |
| Q2 2023 | $3,294,600 | -14.3% | 510,000 | 0.0% | 1.85% | -41.8% |
| Q1 2023 | $3,845,400 | +74336.7% | 510,000 | 0.0% | 3.18% | -42.4% |
| Q4 2022 | $5,166 | -99.9% | 510,000 | 0.0% | 5.52% | -7.1% |
| Q3 2022 | $5,044,000 | +846.3% | 510,000 | +920.0% | 5.95% | +820.9% |
| Q2 2022 | $533,000 | -45.3% | 50,000 | -50.0% | 0.65% | -33.6% |
| Q1 2022 | $975,000 | -54.5% | 100,000 | -33.3% | 0.97% | -42.1% |
| Q4 2021 | $2,145,000 | -28.6% | 150,000 | 0.0% | 1.68% | -31.2% |
| Q3 2021 | $3,006,000 | -8.9% | 150,000 | 0.0% | 2.44% | -28.3% |
| Q2 2021 | $3,300,000 | – | 150,000 | – | 3.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |